DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alimta (Pemetrexed Disodium) - Current Clinical Trials

 
 



Alimta Related Clinical Trials

Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients [Active, not recruiting]

Study of AlimtaŽ (Pemetrexed) Plus VELCADEŽ (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy [Completed]

ZD6474(Vandetanib) + Alimta Combo Study [Active, not recruiting]

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. [Completed]

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer [Completed]

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer [Completed]

Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib [Active, not recruiting]

Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II) [Recruiting]

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer [Active, not recruiting]

A Phase 2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer [Active, not recruiting]

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer [Recruiting]

Efficacy Study of AvastinŽ With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Recruiting]

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Recruiting]

Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer [Active, not recruiting]

AZD6244 Versus Pemetrexed (AlimtaŽ) in Patients With Non-Small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen [Active, not recruiting]

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy [Recruiting]

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer [Recruiting]

Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer [Recruiting]

Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer [Active, not recruiting]

Pemetrexed and Gemcitabine Every 14 Days vs Every 21 Days in Advanced Non Small Cell Lung Cancer [Completed]

Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer [Active, not recruiting]

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer [Recruiting]

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) [Recruiting]

Abraxane and Alimta in Advanced Solid Tumors [Recruiting]

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC [Recruiting]

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases [Recruiting]

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy [Recruiting]

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma [Active, not recruiting]

Trial of Poor Performance Status Patients (ToPPS) [Recruiting]

Trial of BI 6727 Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC [Recruiting]

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer [Recruiting]

BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours [Recruiting]

Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer [Terminated]

BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) [Recruiting]

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer [Recruiting]

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Recruiting]

Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Recruiting]

A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Active, not recruiting]

Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer [Recruiting]

Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer [Recruiting]

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors [Recruiting]

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer [Active, not recruiting]

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Recruiting]

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors [Recruiting]

PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Not yet recruiting]

Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer [Not yet recruiting]

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer [Suspended]

Trial of Motexafin Gadolinium and Pemetrexed (AlimtaŽ) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC [Recruiting]

Modufolin (6R 5,10-Methylenetetrahydrofolate) and Pemetrexed for Neoadjuvant Rectal Cancer Treatment [Recruiting]

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC [Active, not recruiting]

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy [Active, not recruiting]

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer [Completed]

ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer [Completed]

Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC [Recruiting]

Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With EGFR Wild-type Advanced Lung Adenocarcinoma [Recruiting]

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. [Active, not recruiting]

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma [Completed]

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma [Completed]

Pemetrexed in Patients With Advanced Neuroendocrine Tumors [Active, not recruiting]

Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer [Completed]

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. [Completed]

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned [Completed]

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma [Completed]

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial [Completed]

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. [Completed]

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors [Completed]

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Recruiting]

Pemetrexed Disodium and Either Cisplatin or Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer [No longer recruiting]

Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Brain Radiation and Pemetrexed [Recruiting]

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer [Recruiting]

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [No longer recruiting]

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy [Completed]

Stage IV Colorectal CA ALIMTA [Suspended]

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. [Completed]

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma [Completed]

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors [Recruiting]

Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma [No longer recruiting]

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer [Completed]

Pharmaco-Economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer [Recruiting]

Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer [Completed]

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) [Recruiting]

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors [Recruiting]

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies [Recruiting]

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Recruiting]

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate [Recruiting]

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix [Suspended]

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases [Recruiting]

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) Versus Pemetrexed in Advanced Non Small Cell Lung Cancer [Not yet recruiting]

Pemetrexed Plus Gemcitabine in Renal Cell Cancer [Recruiting]

NovoTTF-100L in Combination With Pemetrexed (AlimtaŽ) for Advanced Non-Small Cell Lung Cancer [Recruiting]

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic NSCLC [Recruiting]

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. [Completed]

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM [Recruiting]

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012